Applying artificial intelligence for cancer immunotherapy
Open Access
- 11 February 2021
- journal article
- review article
- Published by Elsevier BV in Acta Pharmaceutica Sinica. B
- Vol. 11 (11), 3393-3405
- https://doi.org/10.1016/j.apsb.2021.02.007
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81803035)
- China Postdoctoral Science Foundation (2020M672521)
- Natural Science Foundation of Hunan Province (2019JJ50932, 2020JJ5934)
- Fundamental Research Funds for Central Universities of the Central South University (2019zzts345, 2019zzts800)
This publication has 144 references indexed in Scilit:
- Genomic correlates of response to CTLA-4 blockade in metastatic melanomaScience, 2015
- Artificial Intelligence, Big Data, and CancerJAMA Oncology, 2015
- Deep learningNature, 2015
- Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancerScience, 2015
- A New Initiative on Precision MedicineThe New England Journal of Medicine, 2015
- Reanalyses of Randomized Clinical Trial DataJAMA, 2014
- Vision 20/20: Perspectives on automated image segmentation for radiotherapyMedical Physics, 2014
- Modeling of tumor growth in dendritic cell-based immunotherapy using artificial neural networksComputational Biology and Chemistry, 2014
- From the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers in cancerCurrent Opinion in Immunology, 2013
- The immune contexture in human tumours: impact on clinical outcomeNature Reviews Cancer, 2012